Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01679236 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study on Mindfulness for Tobacco and Alcohol in University Students
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 55
- Enrollment target
NCT01679236: Completed Early Phase 1 study, sponsored by University of Wisconsin, Madison.
NCT01679236 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 55 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01679236, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
A. The study follows a randomized controlled design with approximately 60 smokers with a history of alcohol abuse age 18-29. The study will compare a 7-week mindfulness intervention to a matched 7-week education intervention to evaluate intervention effect on smoking cessation and reduction in alcohol use. The primary hypothesis is that the mindfulness intervention will yield statistically significantly higher smoking abstinence than controls as measured by carbon monoxide breath test and Time Line Follow Back at at the end of treatment (2-weeks post smoking cessation attempt).
Primary Outcome
Smoking abstinence is measured by Carbon Monoxide Breath Testing in Controls vs Study Group subjects two weeks after the quit day
Interventions
- BEHAVIORAL Mindfulness Training for Smokers
- BEHAVIORAL Interactive Learning for Smokers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-09 |
| Phase | Early Phase 1 |
What the finished NCT01679236 record still lists
NCT01679236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Training for Smokers is the first listed.
NCT01679236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01679236 about?
NCT01679236 is a clinical study titled "Pilot Study on Mindfulness for Tobacco and Alcohol in University Students". A. The study follows a randomized controlled design with approximately 60 smokers with a history of alcohol abuse age 18-29. The study will compare a 7-week mindfulness intervention to a matched 7-week education intervention to evaluate intervention effect on smoking cessation and reduction in alcoh...
What is the current status of trial NCT01679236?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 55 participants. The study started on 2006-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT01679236?
The interventions under investigation include: Mindfulness Training for Smokers (BEHAVIORAL), Interactive Learning for Smokers (BEHAVIORAL).
Who is sponsoring clinical trial NCT01679236?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01679236's enrollment target sits among peer trials
55 458th of 2000 higher than 1,537 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia